{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:44:25Z","timestamp":1785545065911,"version":"3.56.0"},"reference-count":29,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Drug-related deaths worldwide are most commonly attributed to opioids. Opioids and other sedative drugs can cause respiratory depression and airway compromise, leading to hypoxia and death. Device technology and artificial intelligence used to detect drug overdose has the potential to improve outcomes. PneumoWave Ltd has developed a small chest-worn respiratory monitoring device to detect concerning breathing patterns and alert an emergency response.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n The aim of this study is to investigate the feasibility of using the PneumoWave device in hospital patients at risk of respiratory depression.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n This 18-month prospective observational study was performed at the Queen Elizabeth University Hospital, Glasgow. The study investigates the use of the device on 3 groups of patients at risk of respiratory depression due to drugs. This includes patients attending the emergency department (ED) due to sedative drug overdose, patients receiving procedural sedation and analgesia in the ED, and patients receiving general anesthesia in theaters. Consenting participants will have the PneumoWave sensor paired with end-tidal CO\n 2<\/jats:sub>\n monitoring and regular recordings of vital signs. Usability will be tested by administering a questionnaire to the patient, the clinician, and the nurse. The primary end point is to determine the feasibility of gathering respiratory data from a wearable respiratory monitoring device in the ED. Statistical analysis includes comparison of biosensor data against reference physiology time course data.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Trial recruitment was completed on\n \n December 8, 2023. Twenty-five patients were enrolled in group 1 (acute toxicity); 39 patients in group 2 (procedural sedation), including 1 patient who was subsequently withdrawn; and 14 patients in group 3 (acute toxicity), with 2 patients withdrawn. Publication of the study results is anticipated by December 2025.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n This study will explore the feasibility of the PneumoWave device in a variety of clinical contexts in which risk of pharmacologically induced respiratory depression is present. This will provide valuable insight into the use of device technology in individuals at risk of illicit drug\u2013related harm within the relative safety of a hospital setting. A limitation of the study procedure is exclusion of patients with intoxication after sedative drug overdose who lack the capacity to provide informed consent. This study has been designed to acquire feasibility data to demonstrate the potential for continuous respiratory monitoring to improve outcomes for patients who are at risk of drug-induced respiratory depression, inform product development, and inform the design of future pivotal clinical investigations.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/66961","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T22:25:07Z","timestamp":1762467907000},"page":"e66961-e66961","source":"Crossref","is-referenced-by-count":1,"title":["Utilization and Feasibility of a Wearable Device in Patients With Sedative Effects of Drugs: Protocol for a Prospective Observational Study for the Advanced Respiratory Monitoring Events in Drug Toxicity (ARM-ED) Study"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6600-4766","authenticated-orcid":false,"given":"Lisa Christine","family":"Dunlop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0464-3331","authenticated-orcid":false,"given":"Bruce","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8268-0490","authenticated-orcid":false,"given":"Osian","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6659-676X","authenticated-orcid":false,"given":"Chris","family":"Trueman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8520-7224","authenticated-orcid":false,"given":"Christopher","family":"Carlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1531-1157","authenticated-orcid":false,"given":"Robert","family":"Docking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4866-2049","authenticated-orcid":false,"given":"David J","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"R1","unstructured":"World drug report 2023: executive summary. United Nations Office on Drugs and Crime (UNODC); 2023. URL: https:\/\/www.unodc.org\/res\/WDR-2023\/WDR23_Exsum_fin_SP.pdf [Accessed 18-02-2026]"},{"key":"R2","unstructured":"Drug-related deaths in Scotland in 2022. National Records of Scotland; 2023. URL: https:\/\/www.drugsandalcohol.ie\/39424\/1\/drug-related-deaths-22-report.pdf [Accessed 18-02-2026]"},{"key":"R3","unstructured":"Opioid overdose. World Health Organization. 2025. URL: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/opioid-overdose [Accessed 18-02-2026]"},{"key":"R4","unstructured":"European drug report 2023: trends and developments. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); 2023. URL: https:\/\/tls-suchtfragen.de\/wp-content\/uploads\/2024\/04\/Europaeischer-Drogenbericht-2023_englisch.pdf [Accessed 18-02-2026]"},{"key":"R5","unstructured":"Drug overdose deaths. Centers for Disease Control and Prevention (CDC). URL: https:\/\/www.cdc.gov\/nchs\/nvss\/drug-overdose-deaths.htm [Accessed 18-02-2026]"},{"issue":"1","key":"R6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1151\/spp021113","article-title":"The neurobiology of opioid dependence: implications for treatment","volume":"1","author":"Kosten","journal-title":"Sci Pract Perspect"},{"issue":"1","key":"R7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/2049463712438493","article-title":"Basic opioid pharmacology: an update","volume":"6","author":"Pathan","journal-title":"Br J Pain"},{"issue":"2","key":"R8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1124\/jpet.123.001653","article-title":"Ventilatory effects of fentanyl, heroin, and d\u2011methamphetamine, alone and in mixtures, in male rats breathing normal air","volume":"388","author":"Hiranita","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"R9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/bja\/aen094","article-title":"Opioids and the control of respiration","volume":"100","author":"Pattinson","journal-title":"Br J Anaesth"},{"key":"R10","unstructured":"Kang M Galuska MA Ghassemzadeh S . Benzodiazepine toxicity. In: StatPearls [Internet]. StatPearls Publishing; 2023. URL: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482238\/ [Accessed 18-02-2026]"},{"issue":"9","key":"R11","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1177\/02698811221104065","article-title":"Alprazolam-related deaths in Scotland, 2004-2020","volume":"36","author":"Corkery","journal-title":"J Psychopharmacol"},{"issue":"10","key":"R12","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/17425255.2023.2262386","article-title":"Pharmacology of viable mechanism agnostic respiratory stimulants for the reversal of drug-induced respiratory depression in humans","volume":"19","author":"van Lemmen","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.12.020","article-title":"Pharmaceutical opioid overdose deaths and the presence of witnesses","volume":"55","author":"Ogeil","journal-title":"Int J Drug Policy"},{"key":"R14","volume":"257","author":"Aggarwal","journal-title":"Stud Health Technol Inform"},{"issue":"474","key":"R15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau8914","article-title":"Opioid overdose detection using smartphones","volume":"11","author":"Nandakumar","journal-title":"Sci Transl Med"},{"issue":"5","key":"R16","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s11524-023-00779-y","article-title":"Evaluating the impact of Brave Technology Co-op\u2019s novel drug overdose detection and response devices in North America: a retrospective study","volume":"100","author":"Welwean","journal-title":"J Urban Health"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.103038","article-title":"\u201cOpening the door to somebody who has a chance.\u201d - The experiences and perceptions of public safety personnel towards a public restroom overdose prevention alarm system","volume":"88","author":"Buchheit","journal-title":"Int J Drug Policy"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2019.05.041","article-title":"Simple minimally-invasive automatic antidote delivery device (A2D2) towards closed-loop reversal of opioid overdose","volume":"306","author":"Dhowan","journal-title":"J Control Release"},{"issue":"2","key":"R19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1109\/TBCAS.2023.3331272","article-title":"A wearable device towards automatic detection and treatment of opioid overdose","volume":"18","author":"Mesa","journal-title":"IEEE Trans Biomed Circuits Syst"},{"issue":"1","key":"R20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01990-0","article-title":"Closed-loop wearable naloxone injector system","volume":"11","author":"Chan","journal-title":"Sci Rep"},{"issue":"Pt A","key":"R21","doi-asserted-by":"publisher","first-page":"109138","DOI":"10.1016\/j.drugalcdep.2021.109138","article-title":"Wearable biosensors have the potential to monitor physiological changes associated with opioid overdose among people who use drugs: a proof-of-concept study in a real-world setting","volume":"229","author":"Roth","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"R22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/dar.13737","article-title":"What impacts the acceptability of wearable devices that detect opioid overdose in people who use opioids? A qualitative study","volume":"43","author":"Tas","journal-title":"Drug Alcohol Rev"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2022.969642","article-title":"Perceptions on wearable sensor-based interventions for monitoring of opioid therapy: a qualitative study","volume":"4","author":"Chapman","journal-title":"Front Digit Health"},{"issue":"1","key":"R24","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00522-3","article-title":"Willingness to use a wearable device capable of detecting and reversing overdose among people who use opioids in Philadelphia","volume":"18","author":"Kanter","journal-title":"Harm Reduct J"},{"key":"R25","unstructured":"PneumoWave. URL: https:\/\/pneumowave.com\/ [Accessed 18-02-2026]"},{"issue":"1","key":"R26","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00771-4","article-title":"Baseline characteristics of people experiencing homelessness with a recent drug overdose in the PHOENIx pilot randomised controlled trial","volume":"20","author":"Lowrie","journal-title":"Harm Reduct J"},{"issue":"1","key":"R27","volume":"6","author":"Aminiahidashti","journal-title":"Emerg (Tehran)"},{"issue":"24 Suppl","key":"R28","doi-asserted-by":"publisher","first-page":"IV1","DOI":"10.1161\/CIRCULATIONAHA.105.166550","article-title":"2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care","volume":"112","author":"ECC Committee, Subcommittees and Task Forces of the American Heart Association","journal-title":"Circulation"},{"key":"R29","unstructured":"Castor. URL: https:\/\/www.castoredc.com\/ [Accessed 18-02-2026]"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e66961","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:28:18Z","timestamp":1785536898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e66961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":29,"URL":"https:\/\/doi.org\/10.2196\/66961","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"article-number":"v15i1e66961"}}